acetyl CoA carboxylase inhibitors (Bayer)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameacetyl CoA carboxylase inhibitors (Bayer)
Drug Alias Nameandrimidantibacterial agents (Bayer)moiramide Bpyrrolidinedione derivatives (Bayer)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionAcetyl-CoA carboxylase inhibitors
TargetsAcetyl-CoA carboxylase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A